To study the effect of prophylactic zinc in prevention of respiratory infections and Diarrhoea among children.

Evaluation of efficacy of prophylactic intermittent zinc supplementation in reducing the incidence of acute lower respiratory infections and acute diarrhoea in infants: A hospital based, open label randomized control trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045346

Enrollment

166

Registered

2022-09-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Oral Prophylactic Zinc Supplementation: Drop Z and D (20mg/ml) 0.5ml PO OD 2wks At first and second visits Control Intervention1: Oral Zinc free multivitamin: Drop Vi Syneral 0.5ml PO

Eligibility

Inclusion criteria

Inclusion criteria: Infants of age between 6 wks to 6 months coming for vaccination as per National Immunization Schedule

Exclusion criteria

Exclusion criteria: 1. Children received zinc supplementation in past 2months 2. Children with severe illness requiring hospitalization 3. Infants with weight and height for age Suspected Malabsorption syndrome

Design outcomes

Primary

Measure	Time frame
To find out the effect of prophylactic zinc supplementation in the incidence, duration and severity of Diarrhoea and ALRI among infantsTimepoint: First follow up at 1 month 2nd follow up 3 months after the first follow up	—

Secondary

Measure	Time frame
To find out effect of zinc on growth of infantsTimepoint: First follow up at 1 month 2nd follow up 3 months after the first follow up	—

Countries

India

Contacts

Public ContactDr Chandra Mohan Kumar

All India Institute of Medical Sciences, Patna

cmkumar@aiimspatna.org9810730206

Outcome results